IDEXX Laboratories Inc
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, he… Read more
IDEXX Laboratories Inc (IDXX) - Total Assets
Latest total assets as of December 2025: $3.35 Billion USD
Based on the latest financial reports, IDEXX Laboratories Inc (IDXX) holds total assets worth $3.35 Billion USD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
IDEXX Laboratories Inc - Total Assets Trend (1991–2025)
This chart illustrates how IDEXX Laboratories Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
IDEXX Laboratories Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
IDEXX Laboratories Inc's total assets of $3.35 Billion consist of 42.2% current assets and 57.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 5.4% |
| Accounts Receivable | $552.38 Million | 16.5% |
| Inventory | $377.76 Million | 11.3% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1991–2025)
This chart illustrates how IDEXX Laboratories Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: IDEXX Laboratories Inc's current assets represent 42.2% of total assets in 2025, a decrease from 69.3% in 1991.
- Cash Position: Cash and equivalents constituted 5.4% of total assets in 2025, down from 24.4% in 1991.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 1991.
- Asset Diversification: The largest asset category is accounts receivable at 16.5% of total assets.
IDEXX Laboratories Inc Competitors by Total Assets
Key competitors of IDEXX Laboratories Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
|
Optipharm.CO.LTD
KQ:153710
|
Korea | ₩42.32 Billion |
|
Bionet
TWO:1784
|
Taiwan | NT$3.10 Billion |
IDEXX Laboratories Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - IDEXX Laboratories Inc generates 1.28x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, IDEXX Laboratories Inc generates $ 31.62 in net profit.
IDEXX Laboratories Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.23 | 1.31 | 1.77 |
| Quick Ratio | 0.90 | 0.95 | 1.41 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $265.01 Million | $ 331.98 Million | $ 477.14 Million |
IDEXX Laboratories Inc - Advanced Valuation Insights
This section examines the relationship between IDEXX Laboratories Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 31.30 |
| Latest Market Cap to Assets Ratio | 13.83 |
| Asset Growth Rate (YoY) | 1.7% |
| Total Assets | $3.35 Billion |
| Market Capitalization | $46.34 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values IDEXX Laboratories Inc's assets at a significant premium ( 13.83x), suggesting investors see substantial growth potential or unique competitive advantages.
Positive Asset Growth: IDEXX Laboratories Inc's assets grew by 1.7% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for IDEXX Laboratories Inc (1991–2025)
The table below shows the annual total assets of IDEXX Laboratories Inc from 1991 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $3.35 Billion | +1.74% |
| 2024-12-31 | $3.29 Billion | +1.03% |
| 2023-12-31 | $3.26 Billion | +18.68% |
| 2022-12-31 | $2.75 Billion | +12.70% |
| 2021-12-31 | $2.44 Billion | +6.22% |
| 2020-12-31 | $2.29 Billion | +25.22% |
| 2019-12-31 | $1.83 Billion | +19.20% |
| 2018-12-31 | $1.54 Billion | -10.28% |
| 2017-12-31 | $1.71 Billion | +11.94% |
| 2016-12-31 | $1.53 Billion | +3.78% |
| 2015-12-31 | $1.47 Billion | +6.56% |
| 2014-12-31 | $1.38 Billion | +12.49% |
| 2013-12-31 | $1.23 Billion | +11.50% |
| 2012-12-31 | $1.10 Billion | +7.06% |
| 2011-12-31 | $1.03 Billion | +14.90% |
| 2010-12-31 | $897.14 Million | +10.96% |
| 2009-12-31 | $808.53 Million | +5.63% |
| 2008-12-31 | $765.44 Million | +9.01% |
| 2007-12-31 | $702.18 Million | +25.49% |
| 2006-12-31 | $559.56 Million | +14.04% |
| 2005-12-31 | $490.68 Million | -4.58% |
| 2004-12-31 | $514.24 Million | -1.46% |
| 2003-12-31 | $521.88 Million | +25.25% |
| 2002-12-31 | $416.65 Million | +11.67% |
| 2001-12-31 | $373.11 Million | +11.11% |
| 2000-12-31 | $335.80 Million | -6.78% |
| 1999-12-31 | $360.20 Million | -7.76% |
| 1998-12-31 | $390.50 Million | +3.58% |
| 1997-12-31 | $377.00 Million | +0.83% |
| 1996-12-31 | $373.90 Million | +19.65% |
| 1995-12-31 | $312.50 Million | +156.78% |
| 1994-12-31 | $121.70 Million | +24.18% |
| 1993-12-31 | $98.00 Million | +22.96% |
| 1992-12-31 | $79.70 Million | +109.19% |
| 1991-12-31 | $38.10 Million | -- |